JPMorgan Chase & Co’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.87M | Sell |
580,299
-175,022
| -23% | -$2.98M | ﹤0.01% | 2219 |
|
|
2025
Q1 | $14.8M | Buy |
755,321
+241,650
| +47% | +$4.72M | ﹤0.01% | 1897 |
|
|
2024
Q4 | $12.7M | Sell |
513,671
-125,567
| -20% | -$3.11M | ﹤0.01% | 2060 |
|
|
2024
Q3 | $15.7M | Sell |
639,238
-50,827
| -7% | -$1.25M | ﹤0.01% | 1861 |
|
|
2024
Q2 | $16.2M | Buy |
690,065
+224,579
| +48% | +$5.26M | ﹤0.01% | 1781 |
|
|
2024
Q1 | $15.4M | Sell |
465,486
-57,947
| -11% | -$1.91M | ﹤0.01% | 1857 |
|
|
2023
Q4 | $14.2M | Sell |
523,433
-139,122
| -21% | -$3.79M | ﹤0.01% | 1858 |
|
|
2023
Q3 | $15.9M | Sell |
662,555
-45,125
| -6% | -$1.09M | ﹤0.01% | 1661 |
|
|
2023
Q2 | $22.6M | Sell |
707,680
-14,455
| -2% | -$462K | ﹤0.01% | 1476 |
|
|
2023
Q1 | $22.1M | Sell |
722,135
-19,280
| -3% | -$590K | ﹤0.01% | 1414 |
|
|
2022
Q4 | $29M | Sell |
741,415
-13,741
| -2% | -$537K | ﹤0.01% | 1215 |
|
|
2022
Q3 | $36M | Buy |
755,156
+16,296
| +2% | +$776K | 0.01% | 1088 |
|
|
2022
Q2 | $28.6M | Sell |
738,860
-3,809
| -0.5% | -$147K | ﹤0.01% | 1216 |
|
|
2022
Q1 | $42.6M | Buy |
742,669
+9,575
| +1% | +$549K | 0.01% | 1130 |
|
|
2021
Q4 | $58.4M | Buy |
733,094
+106,582
| +17% | +$8.49M | 0.01% | 1024 |
|
|
2021
Q3 | $54.5M | Buy |
626,512
+100,772
| +19% | +$8.77M | 0.01% | 1043 |
|
|
2021
Q2 | $67.7M | Buy |
525,740
+171,252
| +48% | +$22M | 0.01% | 1002 |
|
|
2021
Q1 | $28.4M | Buy |
354,488
+120,030
| +51% | +$9.61M | ﹤0.01% | 1345 |
|
|
2020
Q4 | $19.1M | Buy |
234,458
+59,935
| +34% | +$4.89M | ﹤0.01% | 1462 |
|
|
2020
Q3 | $4.31M | Buy |
174,523
+133,594
| +326% | +$3.3M | ﹤0.01% | 2316 |
|
|
2020
Q2 | $1.15M | Buy |
40,929
+743
| +2% | +$20.8K | ﹤0.01% | 2940 |
|
|
2020
Q1 | $723K | Buy |
+40,186
| New | +$723K | ﹤0.01% | 3126 |
|